Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Testing effectiveness (Phase 2)Looking for participantsNCT06814496What this trial is testingRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsWho this might be right forMelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more University of Arizona 30
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)UnknownNCT03769285What this trial is testingSkin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot TrialWho this might be right forNon-melanoma Skin CancerCarcinoma, Squamous CellCarcinoma, Basal Cell Women's College Hospital 120
Not applicableLooking for participantsNCT05794035What this trial is testingImpact of Hypofractionated Radiotherapy Strategy After Surgery of Skin Carcinomas in Older PatientsWho this might be right forSkin Cancer, Non-Melanoma Assistance Publique - Hôpitaux de Paris 303
Post-approval studies (Phase 4)Study completedNCT00129961What this trial is testingStudy Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant RecipientsWho this might be right forSkin NeoplasmsKidney Transplantation Wyeth is now a wholly owned subsidiary of Pfizer 86
Early research (Phase 1)Active Not RecruitingNCT04606472What this trial is testingSI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Not applicableStudy completedNCT04154163What this trial is testingAppropriate Dosing to Optimise Personalised Cancer TreatmentsWho this might be right forMelanoma Stage IIIMelanoma Stage IVOvarian Cancer+3 more University of Dundee 18
Early research (Phase 1)Study completedNCT02457793What this trial is testingThe Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forNon-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, Melanoma Genentech, Inc. 24
Early research (Phase 1)Looking for participantsNCT07376707What this trial is testingTGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid TumorsWho this might be right forCRC (Colorectal Cancer)Melanoma (Skin Cancer)HCC - Hepatocellular Carcinoma+1 more Hefei TG ImmunoPharma Co., Ltd. 194
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT01307267What this trial is testingPF-05082566 As A Single Agent And In Combination With RituximabWho this might be right forLymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+4 more Pfizer 190
Early research (Phase 1)Looking for participantsNCT07106827What this trial is testingGV20-0251 in Advanced or Refractory Solid TumorsWho this might be right forHCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more West China Hospital 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808515What this trial is testingA Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC)Who this might be right forLocally Advanced Basal Cell Carcinoma Regeneron Pharmaceuticals 135
Early research (Phase 1)Study completedNCT03517488What this trial is testingXmAb®20717 in Subjects With Selected Advanced Solid TumorsWho this might be right forMelanomaBreast CarcinomaHepatocellular Carcinoma+25 more Xencor, Inc. 150
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Not applicableStudy completedNCT03012009What this trial is testingLaser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled TrialWho this might be right forBowen's DiseaseSuperficial Basal Cell Carcinoma University Hospital, Ghent 16
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Study completedNCT03548467What this trial is testingEvaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic CancerWho this might be right forLocally Advanced or Metastatic Solid Tumours Nykode Therapeutics ASA 41